Hybio Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DESMOPRESSIN ACETATE, with a corresponding US DMF Number 31889.
Remarkably, this DMF maintains an Active status since its submission on July 28, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 16, 2018, and payment made on September 08, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II